CD274 and colorectal carcinoma: PD-L1 expression, microsatellite instability (MSI), and deficient mismatch repair (dMMR) have emerged as major predictive markers for the efficacy of ICI therapy (7); however, not all the CRC patients predicted by PD-L1 expression and MSI benefit from ICI therapy.